MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2016 International Congress

    Suicide attempts and Huntington’s disease: Perseveration, not just impulsivity

    O.C. Roman, J.G. Stovall, D.O. Claassen (Nashville, TN, USA)

    Objective: To present the hypothesis that perseveration, not just impulsivity, is a risk factor for suicide attempts in Huntington's disease (HD). Background: The elevated incidence…
  • 2016 International Congress

    Cervical dystonia and quality of life

    S. Tomic, I. Petkovic, T. Pucic, S. Juric, S. Butkovic Soldo (Osijek, Croatia)

    Objective: To evaluate appearance of depression and anxiety in patiens with cervical dystonia and influence of dystonia symptoms on the quality of life. Background: Cervical…
  • 2016 International Congress

    Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease

    K. Zhu, J.J. Van Hilten, J. Marinus (Leiden, Netherlands)

    Objective: The aim of this longitudinal study is to examine which variables are associated with depressive symptoms in Parkinson's disease (PD), as well as to…
  • 2016 International Congress

    Clinical and neuroimaging correlations in early manifest Huntington’s disease patients: Default mode network properties according to resting-state functional MRI

    Y.A. Seliverstov, E.V. Seliverstova, S.A. Klyushnikov, R.N. Konovalov, S.N. Illarioshkin (Moscow, Russia)

    Objective: (1) To compare pattern of spontaneous activity within default mode network (DMN) between early manifest Huntington's disease (HD) patients and healthy controls and (2)…
  • 2016 International Congress

    Clinical characteristics and natural history of oromandibular dystonia

    L. Scorr, S. Factor, H. Jinnah (Atlanta, GA, USA)

    Objective: The overall goal of this study is to better define the clinical characteristics and natural history of oromandibular dystonia (OMD). Background: OMD is a…
  • 2016 International Congress

    Non motor symptoms burden and motor staging of Parkinson’s disease: Evidence for dichotomy and non-motor dominant subtypes from analysis of 249 cases

    K. Ray Chaudhuri, A. Sauerbier, T. Thavayogarajah, A. Rizos, L. Perkins, C. Rodriguez Blazquez, P. Martinez-Martin, On behalf of EUROPAR, the MDS Non-Motor PD Study Group, The NILS Group (London, United Kingdom)

    Objective: To address the co-occurrence of the burden of non-motor symptoms staging (NMSB) and motor severity of Parkinson's disease (PD) using the Hoehn and Yahr…
  • 2016 International Congress

    Anhedonia and its correlation with clinical aspects in Parkinson’s disease

    H. Nagayama (Tokyo, Japan)

    Objective: The aim of this study is to evaluate the characteristics of anhedonia and its correlation with clinical aspects of PD in a relatively large…
  • 2016 International Congress

    Psychiatric disorders and personality traits in patients with functional dystonia

    A. Tomic, M. Svetel, I. Petrovic, N. Dragasevic Miskovic, D. Pesic, M. Mitkovic, A. Potrebic, N. Kresojevic, V.S. Kostic (Belgrade, Serbia)

    Objective: To determine the range of psychiatric disorders and personality traits in patients with functional dystonia (FD). Background: FD is a part of the spectrum…
  • 2016 International Congress

    Effects of antidepressants on gait parameters in Parkinson’s disease

    D. Martinez-Ramirez, J.C. Giugni, W. Deeb, M.S. Okun, C.J. Hass (Gainesville, FL, USA)

    Objective: To compare GAITRite parameters between PD patients on antidepressants with patients who were not on any psychotropic. Background: PD patients have an increased risk…
  • 2016 International Congress

    Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson’s disease: A resting state functional MRI study

    M.C. Wen, S.Y.E. Ng, H.S.E. Heng, Y. Chao, L.L. Chan, E.K. Tan, L.C.S. Tan (Singapore, Singapore)

    Objective: We aimed to improve our understanding of the neuropathology of excessive daytime sleepiness (EDS) in Parkinson's disease (PD). Background: EDS is a common non-motor…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley